Literature DB >> 23182983

CD5+ diffuse large B-cell lymphoma with hemophagocytosis.

Jan K Davidson-Moncada1, Emily McDuffee, Mark Roschewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23182983      PMCID： PMC3574271          DOI： 10.1200/JCO.2012.44.2301

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  29 in total

1.  B-cell lymphoma-associated hemophagocytic syndrome.

Authors:  C Shimazaki; T Inaba; M Nakagawa
Journal:  Leuk Lymphoma       Date:  2000-06

2.  BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Authors:  Javeed Iqbal; Paul N Meyer; Lynette M Smith; Nathalie A Johnson; Julie M Vose; Timothy C Greiner; Joseph M Connors; Louis M Staudt; Lisa Rimsza; Elaine Jaffe; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Wing C Chan
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

3.  De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Authors:  Motoko Yamaguchi; Masao Seto; Masataka Okamoto; Ryo Ichinohasama; Naoya Nakamura; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Takashi Akasaka; Jun-ichi Tamaru; Ritsuro Suzuki; Yoshitoyo Kagami; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

4.  Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.

Authors:  M S Wilson; L M Weiss; K C Gatter; D Y Mason; R F Dorfman; R A Warnke
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

5.  Expression of a T-cell antigen (Leu-1) by B-cell lymphomas.

Authors:  B F Burns; R A Warnke; R S Doggett; R V Rouse
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

6.  Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS.

Authors:  C Shimazaki; T Inaba; A Okano; M Hatsuse; R Takahashi; H Hirai; Y Sudo; E Ashihara; Y Adachi; S Murakami; K Saigo; H Tsuda; N Fujita; M Nakagawa
Journal:  Intern Med       Date:  2001-09       Impact factor: 1.271

7.  Frequent expression of shared idiotypes in mantle cell lymphoma and extranodal small lymphocytic/non-mantle cell diffuse small cleaved lymphoma.

Authors:  T Ohno; K Oka; M Yamaguchi; K Kita; S Shirakawa
Journal:  Leukemia       Date:  1995-11       Impact factor: 11.528

8.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

9.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

Authors:  J H Antin; S G Emerson; P Martin; N Gadol; K A Ault
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

Authors:  Y Levy; J C Brouet
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808
View more
  3 in total

1.  Diffuse Large B-Cell Lymphoma with Secondary Hemophagocytic Lymphohistiocytosis Presenting as Acute Liver Failure.

Authors:  Ruchi Patel; Haren Patel; William Mulvoy; Sumit Kapoor
Journal:  ACG Case Rep J       Date:  2017-05-24

2.  Hemophagocytic lymphohistiocytosis as an onset of diffuse large B-cell lymphoma: A case report.

Authors:  Yueqing Cao; Lang Zou; Hao Zhou; Gan Fu; Xielan Zhao
Journal:  Oncol Lett       Date:  2022-07-05       Impact factor: 3.111

3.  Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

Authors:  Zijun Y Xu-Monette; Meifeng Tu; Kausar J Jabbar; Xin Cao; Alexandar Tzankov; Carol Visco; Lalitha Nagarajan; Qingqing Cai; Santiago Montes-Moreno; Yuji An; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Michael B Møller; John P Farnen; Jane N Winter; Miguel A Piris; Roberto N Miranda; L Jeffrey Medeiros; Ken H Young
Journal:  Oncotarget       Date:  2015-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.